ClinicalTrials.Veeva

Menu

Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)

Children's Hospital of Philadelphia (CHOP) logo

Children's Hospital of Philadelphia (CHOP)

Status

Completed

Conditions

Maple Syrup Urine Disease

Treatments

Behavioral: Neurocognitive testing

Study type

Observational

Funder types

Other

Identifiers

NCT04828863
21-018443

Details and patient eligibility

About

Maple Syrup Urine Disease (MSUD) is a disorder of protein metabolism that leads to neurological differences. It is an exciting time where people diagnosed with MSUD are living longer. The investigators want to learn about how adults with MSUD think, feel, and live. The purpose of this research study is to 1) look at thinking skills, behavior skills, life skills, and quality of life in adults with MSUD and 2) measure how medical and personal factors impact these areas. The results of the study will be used to learn how to best help adults with MSUD and how to prepare for their success. In this study, the participants will answer questions on thinking, life skills, behavior skills, and quality of life. These questions will be completed on the internet. The participants will have a formal testing of their thinking and behavior completed virtually. The participants may also have a 1-2-hour telephone conversation about their life. All tests will occur virtually at home. The investigators will send the participants a letter with the results of thinking and behavior tests.

Enrollment

44 patients

Sex

All

Ages

21 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Index Subjects:

  • Males or females 21 years and older
  • Diagnosis of MSUD
  • Ability to communicate verbally or using augmentative communication effectively to participate in appropriate neurocognitive testing

Inclusion Criteria for Comparison Subjects:

  • Males or females 21 years and older
  • Sibling or acquaintance of index subject
  • Ability to communicate verbally or using augmentative communication effectively to participate in appropriate neurocognitive testing

Exclusion Criteria for all subjects:

  • Inability to communicate verbally or using augmentative communication effectively to participate in appropriate neurocognitive testing
  • Subjects or guardians or who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
  • Subjects or guardians who do not have internet access
  • Subjects who do not speak English as a primary language

Trial design

44 participants in 2 patient groups

Index subjects
Description:
25 young adults with MSUD who are 21 years and older.
Treatment:
Behavioral: Neurocognitive testing
Control subjects
Description:
25 age-matched siblings or acquaintances who do not have MSUD and are 21 years and older
Treatment:
Behavioral: Neurocognitive testing

Trial contacts and locations

1

Loading...

Central trial contact

Jessica Gold

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems